Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

AC Immune Sa

TRADE

NASDAQ: ACIUHealthcare / Biotechnology / Switzerland
8.56-0.20-2.28%Vol 55 2981Y Perf 16.30%
Aug 17th, 2018 16:00
BID3.70 ASK9.50
Open8.80 Previous Close8.76
Pre-Market- After-Trading-
 - -%  - -%
Target Price
24.00 
Analyst Rating
Strong Buy 1.00
Potencial %
180.37 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★     47.75
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★+     46.98
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)564 
Earnings Rating
Price Range Ratio 52wk %
15.49 
Earnings Date

Today's Price Range

8.448.95

 

52wk Range

6.9417.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-29.01%
3 Months
-12.57%
6 Months
-25.26%
1 Year
16.30%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ACIU8.56-0.2000-2.28
AAPL217.584.26002.00
GOOG1 200.96-5.5300-0.46
MSFT107.58-0.0600-0.06
XOM78.260.26000.33
WFC58.860.20000.34
JNJ134.471.99001.50
FB173.80-0.9000-0.52
GE12.300.00000.00
JPM114.770.00000.00
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 9.40
Current Ratio 9.70
Long Term Debt to Total Capital 0.00
Total Debt to Equity 0.00
Interest Coverage -254.90
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-130.00
EBITDA Margin-126.30
Pre-tax Profit Margin-
Profit Margin-78.35
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 6.58
PS Ratios 29.35
Price to Cash Flow 35.80
Price to Free Cash Flow -26.10
Cash Flow Per Share -0.38
Price to Tangible Book6.56
Book Value per Share1.42
Enterprise Value (in ths.)528 592
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -24.86
Return on Assets (5Y Avg) -
ROA last 12 Months -22.06
Return on Capital (5Y Avg) -
ROC last 12 Months -25.22
Return on invested Capital Q -11.06
Return on invested Capital Y-20.46
Assets Turnover0.20
Receivables Turnover9.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)21 529
Revenue per Share 0.32
Revenue Growth 3 Years -17.59
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.23-0.2013.04
Q01 2018-0.23-0.2013.04
Q04 2017-0.06-
Q03 2017-0.20-0.1620.00
Q02 2017-0.07-0.22-214.29
Q01 2017-0.17-0.170.00
----
----
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.2373.86Positive
9/2018 QR-0.2877.60Positive
12/2018 FY-1.05--
12/2019 FY-1.09--
Next Report Date8th Aug 2018
Estimated EPS Next Report-0.23
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume55 298
Shares Outstanding (in ths.)65 860
Trades Count236
Dollar Volume375 347
Avg. Volume110 516
Avg. Weekly Volume70 660
Avg. Monthly Volume256 140
Avg. Quarterly Volume194 409

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

64%36%

Bearish Bullish

72%28%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x